Mr. Christopher J. Calhoun, MBA

Director

Chris has 25 years of leadership experience in medical device and biotech companies. He has completed more than $500 million in financing and partnership transactions including GE Healthcare, Astellas, Olympus Medical, BARDA, Medtronic, and Kensey Nash. Chris was the cofounder of Cytori Therapeutics and served as CEO from 1996 to 2014. He has filed 96 medical patent applications and has delivered more than 100 presentations at financial, technology, and regional medical conferences.

Dr. Soji Swaraj, MBBS, MBA, PhD

Director

Soji is an endocrinologist with particular interest in the entire insulin resistance spectrum and diabetes. After completing his medical degree at the University of Sydney he also completed a Master’s Degree in Business Administration (MBA) and a PhD in molecular Endocrinology, after which he became a fellow of the Royal Australasian College of Physicians. He practices a pre-emptive strategy to mitigate the prevailing escalation of prescription drugs for chronic disease such as diabetes. Soji founded Sydney Metabolic Clinic to bring physicians, nutritionists, naturopath, alternate health tradition practitioners, exercise professionals and bariatric surgeons under one integrated service to explore all options to provide optimal treatment for their patients.

Over two decades of endocrinology practice together wih his interest in business development will be invaluable to bring wealth of knowledge/expertise for the launch of OzStar Therapeutics products.

Soji is currently a consultant endocrinologist and metabolic physician at Department of Endocrinology, Repatriation General Hospital Concord. He also teaches/supervises medical students and registrars at the University of Sydney, the University of New South Wales and the University of Western Sydney.  Soji also offers Endocrinology services in his rooms throughout Campbelltown, Burwood, Moore Park, & Port Macquarie. 

To learn more about Soji’s treatment approaches click here. https://vimeo.com/217983704?embedded=true&source=vimeo_logo&owner=2873929

Dr. Nick N. Gorgani, BE, MBBS, MS Drug Dev, PhD

Managing Director

Nick is the inventor of this technology and founder, president and CEO of OzStar Therapeutics Pty Ltd. He gained multidisciplinary training spanning from chemical engineering to medicine to immunology and to industrial drug development. He is a dynamic leader with over 20 years proven track record in pre-clinical and clinical development from concept to product launch. Immuno-pharmacologist with expertise in in-vitro and in-vivo studies in animal models of inflammatory and autoimmune conditions. Nick has led numerous classes of patented discoveries in infectious disease and autoimmune fields.

 Throughout his career Nick has received numerous government and institutional awards. He is a clinical senior lecturer at the School of Paediatrics and Reproductive Health, University of Adelaide and at the Department of Medicine, University of Sydney. He has trained a number of graduate students and postdoctoral fellows and examined a number of PhD and Master’s degree thesis and peer-reviewed manuscripts for world-leading scientific journals.

Nick has over 13 years of corporate building and management experience. He is an accomplished team builder and strategic planner, seasoned in selecting and managing contract research organizations, academic institutions, and global R&D partnerships, in collaboration with executive team members, to strengthen the company capabilities.